Minocycline and rifampin: proposed treatment regimen for the elimination of meningococci from the nasopharynges of healthy carriers.
D002353:Carrier State / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D008887:Military Medicine; D008911:Minocycline / Q000494:pharmacology / Q000627:therapeutic use; D009154:Mutation; D009302:Nasopharyngeal Diseases / Q000188:drug therapy; D009345:Neisseria meningitidis / Q000187:drug effects*; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use; D013752:Tetracycline / Q000494:pharmacology*
D013752:Tetracycline; D008911:Minocycline; D012293:Rifampin